Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Capital Expenditures: 2013-2024

Historic Capital Expenditures for Soleno Therapeutics (SLNO) over the last 11 years, with Dec 2024 value amounting to $218,000.

  • Soleno Therapeutics' Capital Expenditures rose 150.00% to $5,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $23,000, marking a year-over-year decrease of 96.01%. This contributed to the annual value of $218,000 for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Soleno Therapeutics' Capital Expenditures is $218,000, which was up 1,576.92% from $13,000 recorded in FY2022.
  • Soleno Therapeutics' 5-year Capital Expenditures high stood at $218,000 for FY2024, and its period low was $7,000 during FY2020.
  • For the 2-year period, Soleno Therapeutics' Capital Expenditures averaged around $115,500, with its median value being $115,500 (2022).
  • Per our database at Business Quant, Soleno Therapeutics' Capital Expenditures slumped by 66.67% in 2020 and then spiked by 214.29% in 2021.
  • Soleno Therapeutics' Capital Expenditures (Yearly) stood at $7,000 in 2020, then surged by 214.29% to $22,000 in 2021, then slumped by 40.91% to $13,000 in 2022, then reached $218,000 in 2024.